About

About

Open Field 32 is an independent resource on ibogaine evidence, safety, and treatment claims. Cardia Loom operates the project to support careful understanding of a complex, high‑risk treatment landscape rather than offering clinical services.

Our mission is plainspoken: Cardia Loom is an independent resource on ibogaine research, safety considerations, and the distinctions between clinical evidence and marketing claims. It supports careful understanding of a complex, high‑risk treatment landscape.

Visit our profile of practical offers and editorial scope at Services, or return to the site homepage to explore other pages and summaries that describe our sourcing and methodology in context.

Explore how we organize information

Why we exist

Open Field 32 exists to reduce confusion where clinical claims, promotional materials, and early-stage research overlap. We publish clear summaries and references so readers can separate evidence from marketing and assess safety considerations for themselves.

What we cover

We describe the types of information available — peer-reviewed studies, registry summaries, treatment facility claims, and regulatory guidance — and we organize that material so readers can find primary sources and understand limitations.

How we source information

Our editorial process prioritizes primary literature and official registries. We cross-check clinical reports against registry entries and recognized standards, and we flag claims that lack reproducible evidence or safety data.

Our editorial approach

We use transparent, repeatable practices: tracking citations to peer-reviewed work, cross-referencing clinical registries, and noting when data arise from promotional sources rather than independent studies. For example, readers can consult large reference overviews such as the National Institutes of Health for study indexing and context when evaluating evidence.

We link to authoritative background material as evidence for methodological claims — for instance, registry standards described by NIH and encyclopedic summaries like the scientific method to explain why reproducibility matters.

Editorial principles

  • Safety first — we foreground known risks and data gaps.
  • Evidence over hype — claims must link to sources.
  • Plain language — technical material is summarized for non‑specialists.
  • Transparency — we disclose sourcing and limitations.

Independent by design

Open Field 32 is an independent information resource and does not operate as a clinic or licensed treatment center. We do not provide medical or legal advice. Readers should consult licensed professionals for clinical decisions and verify credentials and licensure when evaluating service providers.

Our site links to and cites published studies, regulated registries, and primary sources; we also link inline to examples of provider sites when relevant so readers can see how claims are presented directly by operators such as the documentary site the ibogaine documentary or facility directories like ibogaine treatment facilities directory. When discussing treatment offerings we may also reference treatment providers' own pages such as Baja Ibogaine Treatment and other operational sites so readers can examine primary promotional claims themselves.

For readers exploring location-specific providers, some pages link to commercial listings like Mexico treatment listings and thematic directories such as ibogaine for opioid addiction resources. We also note non-clinical communities and training organizations in context, for example listing public pages such as ibogaine martial arts as examples of promotional or community-led material we evaluate critically.

To return to the broader site and browse other sections, use the main navigation or follow the path back to the site overview. For descriptions of the editorial services we provide, see the Services page where we explain how material is organized and presented.